3,4-Dihydroxyphenylessigsure

Dopac

HCID 547CAS 102-32-9

Grundinformationen

Standard-SMILES
O=C(O)Cc1ccc(O)c(O)c1
InChIKey
CFFZDZCDUFSOFZ-UHFFFAOYSA-N
Summenformel
C8H8O4
Durchschnittliche Molmasse
168,15 g/mol
Monoisotopische Masse
168,04225874

Überblick

(3,4-dihydroxyphenyl)acetic acid is a dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine. It has a role as a human metabolite. It is a member of catechols and a dihydroxyphenylacetic acid. It is functionally related to a phenylacetic acid. It is a conjugate acid of a (3,4-dihydroxyphenyl)acetate.

Namen und Bezeichner

Bevorzugter Name
Dopac
IUPAC
2-(3,4-dihydroxyphenyl)acetic acid
Lokaler Name
3,4-Dihydroxyphenylessigsure
Englischer Name
3,4-Dihydroxyphenylacetic acid
Summenformel
C8H8O4
Molmasse
168.15

Namen und Synonyme

3,4-Dihydroxyphenylacetic acid102-32-9Dopac2-(3,4-DIHYDROXYPHENYL)ACETIC ACIDHomoprotocatechuic acidDopacetic acidBenzeneacetic acid, 3,4-dihydroxy-Acetic acid, (3,4-dihydroxyphenyl)-BA 2773KEX5N0R4N5NSC-73191DTXSID9074430
Weitere Namen anzeigen
N,N-DIMETHYL-P-PHENYLENEDIAMINE SULFATE3,4-DihydroxyphenyLba2773dopaceticacid
HMDB013363,4 Dihydroxyphenylacetic AcidRefChem:486240DTXCID3032676203-024-13,4-Dihydroxybenzeneacetic acidDihydroxyphenylacetic acid(3,4-DIHYDROXYPHENYL)ACETIC ACID

Datenbank-Bezeichner

CAS
102-32-9
PubChem CID
547
DTXSID
DTXSID9074430
ChEMBL
CHEMBL1284
ChEBI
CHEBI:41941
UNII
KEX5N0R4N5
EC Number
203-024-1
Nikkaji
J804D

Eigenschaften

Berechnete Struktureigenschaften

XLogP
0,5
Polarare Oberfläche (TPSA)
77,8 Ų
H-Brücken-Donoren
3
H-Brücken-Akzeptoren
4
Frei drehbare Bindungen
2
Schwere Atome
12

Experimentelle und physikochemische Eigenschaften

Chemical ClassesOther Classes -> Organic Acids
DrugsPharmaceuticals -> Listed in ZINC15
LogP · 2 Einträge

0.98

0.98

Solubility4 mg/mL
Melting Point168 °C
Vapor Pressure0.00000082 [mmHg]

Physikochemische Eigenschaften

Schmelzpunkt
127 · 127-130 °C (lit.)
Siedepunkt
257.07 °C · 257.07°C (rough estimate)
Dichte
1.3037 · 1.3037 (rough estimate)
Brechungsindex
1.509 · 1.5090 (estimate)
storage temp.
Inert atmosphere,Room Temperature
Löslichkeit
50 mg/mL, · water: soluble50mg/mL, clear, almost colorless

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 45 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Hazards SummaryA skin and strong eye irritant; [Alfa Aesar MSDS]
Hazard Classes and CategoriesSkin Irrit. 2 (100%)

Sicherheitsdaten

F
10-23
wgk
3
hs_code
29182900
RTECS-Nr.
AH0590000
risk_code
36/37/38
hazard_code
Xi

Chemie und Industrie

Pharmakologische Informationen

Metabolism/Metabolites3,4-dihydroxyphenylacetic acid has known human metabolites that include 3-hydroxyphenylacetic acid, 4-hydroxyphenylacetic acid, and Protocatehuic acid.
Tissue LocationsBrain
Cellular LocationsCytoplasm
Metabolite PathwaysAlkaptonuria

Verwendung und Herstellung

UsesA deaminated metabolite of LEVODOPA. [ChemIDplus]
Anwendungen · 2 Einträge

Beschreibung3,4-Dihydroxyphenylacetic acid (DOPAC) is a metabolite of the neurotransmitter dopamine. Dopamine can be metabolized into one of three substances. One such substance is DOPAC. Another is 3-methoxytyramine (3-MT). Both of these substances are degraded to form homovanillic acid (HVA). Both degradations involve the enzymes monoamine oxidase (MAO) and catechol-O-methyl transferase (COMT), albeit in reverse order: MAO catalyzes dopamine to DOPAC, and COMT catalyzes DOPAC to HVA; whereas COMT catalyzes dopamine to 3-MT and MAO catalyzes 3-MT to HVA. The third metabolic end-product of dopamine is norepinephrine (noradrenaline).DOPAC can be oxidized by hydrogen peroxide, leading to the formation of toxic metabolites which destroy dopamine storage vesicles in the substantia nigra. This may contribute to the failure of levodopa treatment of Parkinson's disease. A MAO-B inhibitor such as selegiline or rasagiline can prevent this from happening.wikipedia

Verwenden3,4-Dihydroxyphenylacetic Acid is a metabolite of Dopamine (D533782).

Anbieter50 Anbieter

国药集团化学试剂有限公司86-21-63210123 · [email protected]
北京华美互利生物化工010-56205725 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
Shanghai Biolang Biotechnology Co., Ltd.+86-15970428662 +86-13397199602 · [email protected]

Zugehörige Reaktionen

20

Verknüpfte Notizen

Wird geladen…